The Martin Delaney Collaboratories for HIV Cure Research is the flagship NIH program on HIV cure research.
The purpose is to foster dynamic, multidisciplinary collaborations between basic, applied, and clinical researchers studying HIV persistence and developing potential curative strategies. This is accomplished by establishing partnerships across academia, industry, government, and community, with a goal of leveraging common resources to accelerate the pace of HIV cure research and engage the next generation of HIV cure researchers.
The program was launched in July 2011 with the funding of three Collaboratories: CARE, DARE, and defeatHIV. In July 2016, the program was expanded to include three additional Collaboratories (BELIEVE, BEAT-HIV, and I4C) for a total of six Collaboratories, supporting a total of approximately 300 researchers. In 2021, the program was further expanded to 10 Collaboratories, with one of them focused specifically on HIV cure research in infants and children.
PAVE Grant Number: UM1AI164566
